CSPC Pharmaceutical Group Limited
CSPCY | OTC
$4.07
+$0.13 (+3.30%)
Nov 2, 2026, 10:20 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 6.09B | 6.37B | 12.02B | 10.3B | 9.27B | 7.28B |
Short-Term Investments | 2.78B | 1.38B | 1.08B | 3.57B | 1.44B | 1.53B |
Long-Term Investments | 7.18B | 6.32B | 4.64B | 3.73B | 3.6B | 3.92B |
Other Long-Term Assets | 556.73M | 168.55M | 819.64M | -161.75M | 419.13M | 354.5M |
Receivables | 9.55B | 9.33B | 10.84B | 7.53B | 6.74B | 4.87B |
Inventory | 3.09B | 3.13B | 3.14B | 2.55B | 2.48B | 1.86B |
Other Current Assets | 534.26M | 1.47B | 10.36B | -693.22M | 360.86M | 349.21M |
Total Current Assets | 22.26B | 21.87B | 26.74B | 23.96B | 20.3B | 15.88B |
Property-Plant & Equipment | 13.5B | 13.07B | 11.64B | 11.77B | 9.55B | 8.91B |
Goodwill & Intangibles | 3.01B | 2.67B | 2.43B | 2.34B | 766.44M | 806.72M |
Total Long-Term Assets | 24.46B | 22.49B | 19.54B | 17.81B | 14.38B | 14.11B |
Total Assets | 46.72B | 44.36B | 46.28B | 41.18B | 34.68B | 30B |
Account Payables | 2.98B | 2.45B | 2.84B | 2.01B | 1.32B | 1.24B |
Deferred Revenue | 662.53M | 283.76M | n/a | n/a | 427.63M | 624.16M |
Short-Term Debt | 328.72M | 392.2M | 450.22M | 153.48M | 38.35M | 223.28M |
Other Current Liabilities | 5.85B | 647.69M | 494.9M | 326.44M | 954.33M | 3.44B |
Total Current Liabilities | 10.18B | 9.63B | 10.18B | 8.96B | 7.21B | 6.29B |
Long-Term Debt | n/a | n/a | n/a | 28.95M | n/a | n/a |
Other Long-Term Liabilities | 563.48M | 1 | 56.96M | n/a | 250.2M | 253.97M |
Total Long-Term Liabilities | 1.97B | 888.67M | 738.86M | 1.17B | 687.3M | 666.75M |
Total Liabilities | 12.15B | 10.52B | 11.26B | 10.06B | 7.91B | 6.97B |
Total Debt | 641.38M | 507.33M | 706.9M | 582.54M | 93.87M | 440.82M |
Book Value | 34.56B | 33.85B | 35.02B | 31.11B | 26.77B | 23.03B |
Book Value Per Share | 3.03 | 2.88 | 2.95 | 2.61 | 2.24 | 1.93 |
Common Stock | 11.07B | 11.03B | 11.99B | 10.75B | 10.88B | 10.87B |
Retained Earnings | 24.48B | 23.33B | 26.46B | 20.84B | 17.24B | 13.29B |
Comprehensive Income | n/a | n/a | -1.56B | -1.73B | -2.09B | -1.78B |
Shareholders Equity | 33.19B | 32.24B | 33.2B | 29.77B | 25.94B | 22.28B |
Total Investments | 9.96B | 7.71B | 5.72B | 7.25B | 5.04B | 5.45B |
Add to Watchlist
Select watchlists to add or remove CSPCY